An atypical subtrochanteric femoral fracture from pycnodysostosis: A lesson from nature

Journal of Bone and Mineral Research

Volumn 26, Issue 6, 2011, Pages 1377-1379

  Yates, Christopher J ^a   Bartlett, Miriam J ^a   Ebeling, Peter R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antiresorptive Drugs; Atypical Subtrochanteric Femoral Fracture; Osteoclasts; Osteoporosis; Pycnodysostosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K; COLLAGEN TYPE 1; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTERIOR FONTANEL; ARTICLE; BONE DENSITOMETRY; BONE PLATE; BONE RADIOGRAPHY; BONE SCREW; BONE TURNOVER; CALCIUM BLOOD LEVEL; CASE REPORT; COMPETITIVE INHIBITION; DENTITION; ENZYME INHIBITION; FEMUR SUBTROCHANTERIC FRACTURE; GENE MUTATION; HUMAN; HYPOCALCIURIA; LUMBAR SPINE; MALE; MICROGNATHIA; OPEN REDUCTION; OSTEOCLAST; OSTEOPOROSIS; OSTEOSYNTHESIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PYCNODYSOSTOSIS; SECONDARY HYPERPARATHYROIDISM; SHORT STATURE; VITAMIN D DEFICIENCY;

ADULT; FEMORAL FRACTURES; HIP FRACTURES; HUMANS; MALE; PELVIS; PYCNODYSOSTOSIS; SKULL;

EID: 79958852968     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.308     Document Type: Article

References (21)

1. Maroteaux P, Lamy M,. La Pycnodysostose. Presse Med. 1962; 70: 999.
2. Everts V, Aronson DC, Beertsen W,. Phagocytosis of bone-collagen by osteoclasts in 2 cases of pycnodysostosis. Calcif Tissue Int. 1985; 37: 25-231.
3. Gelb BD, Edelson JG, Desnick RJ,. Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nat Genet. 1995; 10: 235-237.
4. Ho N, Punturieri A, Wilkin D, et al. Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein. J Bone Miner Res. 1999; 14: 1649-1653. (Pubitemid 29455812)
5. Johnson MR, Polymeropoulos MH, Vos HL, deLuna RIO, Francomano CA,. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res. 1996; 6: 1050-1055. (Pubitemid 26413616)
6. Gelb BD, Shi GP, Chapman HA, Desnick RJ,. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996; 273: 1236-1238.
7. Kumar S, Jerome C, Stroup G,. SB-462795 (relacatib), a cathepsin inhibitor, prevents the loss of bone mass at several sites in ovariectomized cynomolgus monkeys. Osteoporos Int. 2006; 17: S14.
8. Adami S, Supronik J, Hala T, et al. Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis. J Bone Miner Res. 2006; 21: S24.
9. Peroni A, Zini A, Braga V, Colato C, Adami S, Girolomoni G,. Drug-induced morphea: report of a case induced by balicatib and review of the literature. J Am Acad Dermatol. 2008; 59: 125-129.
10. Bone HG, McClung MR, Roux C, et al. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res. 2010; 25: 937-947.
11. Roth VG,. Pycnodysostosis presenting with bilateral subtrochanteric fractures: case report. Clin Orthop Rel Res. 1976; 247-253.
12. Nakase T, Yasui N, Hiroshima K, et al. Surgical outcomes after treatment of fractures in femur and tibia in pycnodysostosis. Arch Orthop Trauma Surg. 2007; 127: 161-1615.
13. Kundu ZS, Marya KM, Devgan A, Yadav V, Rohilla S,. Subtrochanteric fracture managed by intramedullary nail in a patient with pycnodysostosis. Joint Bone Spine. 2004; 71: 154-156. (Pubitemid 38407227)
14. Amit S, Shehkar A, Vivek M, Shekhar S, Biren N,. Fixation of subtrochanteric fractures in two patients with osteopetrosis using a distal femoral locking compression plate of the contralateral side. Eur J Trauma Emerg Surg. 2010; 36: 263-269.
15. Birmingham P, McHale KA,. Case reports: treatment of subtrochanteric and ipsilateral femoral neck fractures in an adult with osteopetrosis. Clin Orthop Rel Res. 2008; 466: 2002-2008.
16. Gagnon C, Sims NA, Mumm S, et al. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab. 2010; 95: 1007-1012.
17. Whyte MP,. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009; 24: 1132-1134.
18. Lenart BA, Lorich DG, Lane JM,. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008; 358: 1304-1306. (Pubitemid 351439247)
19. Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D,. Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases. J Bone Miner Res. 2008; 23: 1698-1707.
20. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25: 2267-2294.
21. Black DM, Kelly MP, Genant HK, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010; 362: 1761-1771.